Insulin lispro Subcutaneous and Pexidartinib Hydrochloride
Determining the interaction of Insulin lispro Subcutaneous and Pexidartinib Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: pexidartinib
Brand name: Turalio
Synonyms: Pexidartinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Pfizerpen
- Insulin lispro Subcutaneous-Pharaon Tea
- Insulin lispro Subcutaneous-Pharmorubicin Pfs
- Insulin lispro Subcutaneous-Phazyme
- Insulin lispro Subcutaneous-Phazyme Liquid Gas Relief, Maximum Strength
- Insulin lispro Subcutaneous-Phena-Plus
- Pexidartinib Hydrochloride-Insulin NPH
- Pexidartinib Hydrochloride-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Pexidartinib Hydrochloride-Insulin NPH (Vials)
- Pexidartinib Hydrochloride-Insulin NPH and Insulin Regular
- Pexidartinib Hydrochloride-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Pexidartinib Hydrochloride-Insulin NPH and Insulin Regular (Vials)